NCT04503746View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis

PHASE2CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

December 13, 2021

Study Completion Date

December 13, 2021

Conditions
Chronic Periodontitis
Interventions
DRUG

ALH-L1005 600mg/day

ALH-L1005 300mg 2 tablet and placebo 2 tablet

DRUG

ALH-L1005 1,200mg/day

ALH-L1005 300mg 4 tablet

DRUG

Placebo

Placebo 4 tablet

Trial Locations (1)

34015

AngioLab, Inc., Daejeon

All Listed Sponsors
lead

AngioLab, Inc.

INDUSTRY

NCT04503746 - A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis | Biotech Hunter | Biotech Hunter